CAPR

8.95

0.11% 0.010

Dopo l'orario di chiusura: 9.03 0.08 +0.89%

Capricor Therapeutics Inc (CAPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CAPR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$8.94

Aprire:

$9.14

Volume 24 ore:

2.54M

Relative Volume:

0.40

Capitalizzazione di mercato:

$520.34M

Reddito:

$11.13M

Utile/perdita netta:

$-114.59M

Rapporto P/E:

-3.8694

EPS:

-2.313

Flusso di cassa netto:

$-113.96M

1 W Prestazione:

+7.06%

1M Prestazione:

-9.50%

6M Prestazione:

-72.13%

1 anno Prestazione:

+12.30%

Intervallo 1D:

$8.7704

$9.24

Intervallo di 1 settimana:

$8.1517

$10.72

Portata 52W:

$2.96

$40.37

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Nome

Capricor Therapeutics Inc

Settore

Healthcare (1064)

Industria

Biotechnology (595)

Telefono

(310) 358-3200

Indirizzo

10865 ROAD TO THE CURE, SAN DIEGO, CA

Dipendente

231

Cinguettio

@Capricor

Prossima data di guadagno

2026-11-09

Ultimi documenti SEC

CAPR's Discussions on Twitter

Compare CAPR vs VRTX, MRNA, REGN, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CAPR Capricor Therapeutics Inc	8.95	486.04M	11.13M	-114.59M	-113.96M	-2.313
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-30	Iniziato	Alliance Global Partners	Buy
2025-06-26	Iniziato	B. Riley Securities	Buy
2025-05-20	Iniziato	Roth Capital	Buy
2024-10-21	Iniziato	Piper Sandler	Overweight
2024-05-17	Iniziato	Oppenheimer	Outperform
2024-01-05	Iniziato	Cantor Fitzgerald	Overweight
2022-10-26	Iniziato	Ladenburg Thalmann	Buy
2018-12-26	Downgrade	Maxim Group	Buy → Hold
2018-01-26	Reiterato	H.C. Wainwright	Buy
2017-09-15	Reiterato	H.C. Wainwright	Buy
2017-02-13	Ripresa	Rodman & Renshaw	Buy
2016-07-06	Ripresa	H.C. Wainwright	Buy
2016-06-15	Iniziato	ROTH Capital	Buy

Mostra tutto

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

Sep 30, 2026

CAPR Stock Jumps As Street Hikes Price Targets Into FDA Catalyst - StocksToTrade

Sep 30, 2026

Capricor Therapeutics, Inc. stock Analysis: Bearish Trend and Intraday Pause - The Cryptonomist

Sep 30, 2026

Sep 29, 2026

Capricor Therapeutics (CAPR) Shares Surge on Positive Phase 3 Da - GuruFocus

Sep 29, 2026

Capricor jumps as study shows longer-term effects of deramiocel (CAPR:NASDAQ) - Seeking Alpha

Sep 29, 2026

Why Did CAPR Stock Jump 20% After-Hours Today? - Yahoo Finance

Sep 29, 2026

Total equity of Capricor Therapeutics, Inc. – HAN:4LN2 - TradingView

Sep 29, 2026

Sep 28, 2026

Recover Investment Losses: Class Action Initiated Against Capricor Therapeutics, Inc. (CAPR) - ACCESS Newswire

Sep 28, 2026

CAPR CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 - Rutland Herald

Sep 28, 2026

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire

Sep 28, 2026

SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026CAPR - PR Newswire

Sep 28, 2026

Sep 26, 2026

CAPR 2-DAY DEADLINE ALERT: Capricor Therapeutics, Inc. - GlobeNewswire

Sep 26, 2026

CAPR 2-DAY DEADLINE ALERT: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline - GlobeNewswire Inc.

Sep 26, 2026

CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 - FinancialContent

Sep 26, 2026

(CAPR) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Sep 26, 2026

Class Action Lawsuit Filed: Capricor Therapeutics, Inc. (CAPR)Join by September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 26, 2026

Sep 25, 2026

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - The Globe and Mail

Sep 25, 2026

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 | FinancialContent - FinancialContent

Sep 25, 2026

Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR)Levi & Korsinsky Reminds Investors of September 28, 2026 - ACCESS Newswire

Sep 25, 2026

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) InvestorsLead Plaintiff Deadline on September 28, 2026 - ACCESS Newswire

Sep 25, 2026

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline - ACCESS Newswire

Sep 25, 2026

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 25, 2026

CAPRICOR DEADLINE SEPTEMBER 28th: Bragar Eagel & Squire, - GlobeNewswire

Sep 25, 2026

CAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - Stocktwits

Sep 25, 2026

Did You Lose Money on Capricor Therapeutics, Inc. (CAPR)? Levi & Korsinsky Urges Investors to Act Before September 28, 2026 - ACCESS Newswire

Sep 25, 2026

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 25, 2026

Sep 24, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire

Sep 24, 2026

Investors in Capricor Therapeutics, Inc. (CAPR): Protect Your RightsContact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire

Sep 24, 2026

Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)Lead Plaintiff Deadline is September 28, 2026 - The Globe and Mail

Sep 24, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire

Sep 24, 2026

September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky - ACCESS Newswire

Sep 24, 2026

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) Shareholders of Class Action Lawsuit and September 28, 2026 Deadline - ACCESS Newswire

Sep 24, 2026

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 24, 2026

CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

Sep 24, 2026

CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Sep 24, 2026

Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire

Sep 24, 2026

Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026 - The Globe and Mail

Sep 24, 2026

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Sep 24, 2026

Contact Levi & Korsinsky by September 28, 2026 to Join Class Action Against Capricor Therapeutics, Inc. (CAPR) - ACCESS Newswire

Sep 24, 2026

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire

Sep 24, 2026

Sep 23, 2026